Actuate Therapeutics ACTU
NASDAQ ACTU
$0.79 +0.10 (+14.96%)
As of: Sep 30, 2026 · 12:19 PM EDT

Actuate Therapeutics, Inc. (ACTU) Net Cash Flow (2023 - 2025)

Updated

Actuate Therapeutics' Net Cash Flow came in at -$3.77 million for Q4 2025, compared with -$4.88 million a year earlier.

Analysis

Actuate Therapeutics, Inc. (ACTU) Net Cash Flow (2023 - 2025) Analysis & Trends

For FY2025, Actuate Therapeutics' Net Cash Flow was $4.52 million, down 20.5% from FY2024.

  • Going back by year, Net Cash Flow was $5.68 million in FY2024 and -$17.49 million in FY2023.
  • The five-year range for quarterly Net Cash Flow is -$5.64 million (Q3 2023) to $13.17 million (Q3 2024).
  • Business Quant data shows ACTU's Net Cash Flow at $10.43 million (Q3 2025), $2.6 million (Q2 2025) and -$4.75 million (Q1 2025) in the three quarters before Q4 2025.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -3.77 Mn
Sep 30, 2025 10.43 Mn
Jun 30, 2025 2.60 Mn
Mar 31, 2025 -4.75 Mn
Dec 31, 2024 -4.88 Mn
Sep 30, 2024 13.17 Mn
Jun 30, 2024 -1.72 Mn
Mar 31, 2024 -890,352.00
Dec 31, 2023 -5.51 Mn
Sep 30, 2023 -5.64 Mn
API Access

Actuate Therapeutics, Inc. Net Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-cash-flow&ticker=ACTU&period=max&api_key=YOUR_API_KEY